111 related articles for article (PubMed ID: 27781256)
1. [Expression of tumor necrosis factor-like weak inducer of apoptosis in patients with gastric cancer and its relationship with nutritional status].
Lu H; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1165-1169. PubMed ID: 27781256
[TBL] [Abstract][Full Text] [Related]
2. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end products attenuate the function of tumor necrosis factor-like weak inducer of apoptosis to regulate the inflammatory response.
Watanabe M; Toyomura T; Wake H; Liu K; Teshigawara K; Takahashi H; Nishibori M; Mori S
Mol Cell Biochem; 2017 Oct; 434(1-2):153-162. PubMed ID: 28455790
[TBL] [Abstract][Full Text] [Related]
4. Increased muscle proteasome activity correlates with disease severity in gastric cancer patients.
Bossola M; Muscaritoli M; Costelli P; Grieco G; Bonelli G; Pacelli F; Rossi Fanelli F; Doglietto GB; Baccino FM
Ann Surg; 2003 Mar; 237(3):384-9. PubMed ID: 12616123
[TBL] [Abstract][Full Text] [Related]
5. Sputum TWEAK expression correlates with severity and degree of control in non-eosinophilic childhood asthma.
Kim SY; Kim JD; Sol IS; Kim MJ; Kim MN; Hong JY; Kim HR; Kim YH; Lee YJ; Kim KW; Sohn MH
Pediatr Allergy Immunol; 2018 Feb; 29(1):42-49. PubMed ID: 29068159
[TBL] [Abstract][Full Text] [Related]
6. [Methylation status and expression of
Lou X; Liao L; Li XJ; Wang N; Liu S; Cui RM; Xu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1020-1025. PubMed ID: 34916675
[TBL] [Abstract][Full Text] [Related]
7. Status of TWEAK DNA methylation and mRNA expression in systemic lupus erythematosus.
Liao L; Li S; Upreti B; Wang X; Yang Y; Lou X; Li L; Cui R; Liu S; Cheng Y; Xu J
Lupus; 2023 Feb; 32(2):171-179. PubMed ID: 36418949
[TBL] [Abstract][Full Text] [Related]
8. [Expression of TWEAK/Fn14 in Pancreatic Cancer].
Wei AL; Guo Q; Gong S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 48(1):154-157. PubMed ID: 28612578
[TBL] [Abstract][Full Text] [Related]
9. [Expression of TWEAK and Its Receptor CD163 in Peripheral Blood of Psoriasis Vulgaris (PV)].
Yang BC; Li MM; Deng XQ; Cao NN; Guo ZP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Sep; 49(5):720-724. PubMed ID: 30378333
[TBL] [Abstract][Full Text] [Related]
10. Expression of tumor necrosis factor-like weak inducer of apoptosis in human middle ear cholesteatoma.
Park M; Lee B; Lee J
ORL J Otorhinolaryngol Relat Spec; 2013; 75(4):221-7. PubMed ID: 23900149
[TBL] [Abstract][Full Text] [Related]
11. Interferon-Gamma and Tumor Necrosis Factor-Related Weak Inducer of Apoptosis Expression in Neoangiogenesis in Colorectal Polypoid Lesions.
Ruffolo C; Toffolatti L; Massani M; Pozza A; Campo Dell'Orto M; Saadeh LM; Ferrara F; Benvenuti S; Dei Tos AP; Bassi N; Kotsafti A; Scarpa M
Eur Surg Res; 2019; 60(5-6):186-195. PubMed ID: 31597147
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of expression of silencing information regulator 2 related enzyme 1 and tumor necrosis factor-like weak inducer of apoptosis in articular effusion and knee osteoarthritis].
Wang Q; Bi L; Ma J
Zhongguo Gu Shang; 2023 Nov; 36(11):1052-7. PubMed ID: 38012874
[TBL] [Abstract][Full Text] [Related]
13. [Prediction Value of TWEAK/Fn14 in Crohn's Disease with Intestinal Fibrosis].
Xu T; Yang Y; Zhao L; Zhou DD; Zhang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 48(5):721-726. PubMed ID: 29130664
[TBL] [Abstract][Full Text] [Related]
14. Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
Clin Exp Immunol; 2006 Dec; 146(3):540-9. PubMed ID: 17100776
[TBL] [Abstract][Full Text] [Related]
15. Increased muscle ubiquitin mRNA levels in gastric cancer patients.
Bossola M; Muscaritoli M; Costelli P; Bellantone R; Pacelli F; Busquets S; Argilès J; Lopez-Soriano FJ; Civello IM; Baccino FM; Rossi Fanelli F; Doglietto GB
Am J Physiol Regul Integr Comp Physiol; 2001 May; 280(5):R1518-23. PubMed ID: 11294777
[TBL] [Abstract][Full Text] [Related]
16. Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis.
Kataria NG; Bartold PM; Dharmapatni AA; Atkins GJ; Holding CA; Haynes DR
J Periodontal Res; 2010 Aug; 45(4):564-73. PubMed ID: 20546112
[TBL] [Abstract][Full Text] [Related]
17. The tumor necrosis factor superfamily members TWEAK, TNFSF15 and fibroblast growth factor-inducible protein 14 are upregulated in proliferative diabetic retinopathy.
Abu El-Asrar AM; De Hertogh G; Nawaz MI; Siddiquei MM; Van den Eynde K; Mohammad G; Opdenakker G; Geboes K
Ophthalmic Res; 2015; 53(3):122-30. PubMed ID: 25676319
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of TWEAK in patients with psoriasis vulgaris.
Bilgiç Ö; Sivrikaya A; Toker A; Ünlü A; Altınyazar C
Cytokine; 2016 Jan; 77():10-3. PubMed ID: 26499979
[TBL] [Abstract][Full Text] [Related]
19. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.
Park MC; Chung SJ; Park YB; Lee SK
Scand J Rheumatol; 2008; 37(3):173-8. PubMed ID: 18465450
[TBL] [Abstract][Full Text] [Related]
20. The C-terminal region of tumor necrosis factor like weak inducer of apoptosis is required for interaction with advanced glycation end products.
Watanabe M; Toyomura T; Wake H; Liu K; Teshigawara K; Takahashi H; Nishibori M; Mori S
Biotechnol Appl Biochem; 2019 Mar; 66(2):254-260. PubMed ID: 30403295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
